Human Microbiome Market Research Report by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, and Mental Disorders), by Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, and Metagenomic Sequencing), by Product, by Therapeutic Area, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Human Microbiome Market is expected to grow from USD 718.37 Million in 2019 to USD 2,406.59 Million by the end of 2025.
2. The Global Human Microbiome Market is expected to grow from EUR 641.41 Million in 2019 to EUR 2,110.14 Million by the end of 2025.
3. The Global Human Microbiome Market is expected to grow from GBP 562.95 Million in 2019 to GBP 1,875.92 Million by the end of 2025.
4. The Global Human Microbiome Market is expected to grow from JPY 78,308.04 Million in 2019 to JPY 256,844.13 Million by the end of 2025.
5. The Global Human Microbiome Market is expected to grow from AUD 1,033.52 Million in 2019 to AUD 3,494.68 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Human Microbiome to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Autoimmune Disorders is projected to witness the highest growth during the forecast period'
Based on Disease, the Human Microbiome Market studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity. The Autoimmune Disorders commanded the largest size in the Human Microbiome Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Metagenomic Sequencing is projected to witness the highest growth during the forecast period'
Based on Technology, the Human Microbiome Market studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology. The Cell Culture Technology commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Metagenomic Sequencing is expected to grow at the fastest CAGR during the forecast period.
'The Drugs is projected to witness the highest growth during the forecast period'
Based on Product, the Human Microbiome Market studied across Diagnostic Devices, Drugs, Foods, and Prebiotic & Probiotics. The Drugs commanded the largest size in the Human Microbiome Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Women’s Health is projected to witness the highest growth during the forecast period'
Based on Therapeutic Area, the Human Microbiome Market studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health. The Gastrointestinal Disorders commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Women’s Health is expected to grow at the fastest CAGR during the forecast period.
'The Diagnostics is projected to witness the highest growth during the forecast period'
Based on Application, the Human Microbiome Market studied across Diagnostics and Therapeutics. The Therapeutics commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Human Microbiome Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market including DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Ferring Holding SA, Merck Sharp & Dohme Corp., Metabiomics Corporation, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences, Inc., and Yakult Honsha Co., Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Microbiome Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Human Microbiome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Microbiome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Microbiome Market?
4. What is the competitive strategic window for opportunities in the Global Human Microbiome Market?
5. What are the technology trends and regulatory frameworks in the Global Human Microbiome Market?
6. What are the modes and strategic moves considered suitable for entering the Global Human Microbiome Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Human Microbiome Market is expected to grow from USD 718.37 Million in 2019 to USD 2,406.59 Million by the end of 2025.
2. The Global Human Microbiome Market is expected to grow from EUR 641.41 Million in 2019 to EUR 2,110.14 Million by the end of 2025.
3. The Global Human Microbiome Market is expected to grow from GBP 562.95 Million in 2019 to GBP 1,875.92 Million by the end of 2025.
4. The Global Human Microbiome Market is expected to grow from JPY 78,308.04 Million in 2019 to JPY 256,844.13 Million by the end of 2025.
5. The Global Human Microbiome Market is expected to grow from AUD 1,033.52 Million in 2019 to AUD 3,494.68 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Human Microbiome to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Autoimmune Disorders is projected to witness the highest growth during the forecast period'
Based on Disease, the Human Microbiome Market studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity. The Autoimmune Disorders commanded the largest size in the Human Microbiome Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Metagenomic Sequencing is projected to witness the highest growth during the forecast period'
Based on Technology, the Human Microbiome Market studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology. The Cell Culture Technology commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Metagenomic Sequencing is expected to grow at the fastest CAGR during the forecast period.
'The Drugs is projected to witness the highest growth during the forecast period'
Based on Product, the Human Microbiome Market studied across Diagnostic Devices, Drugs, Foods, and Prebiotic & Probiotics. The Drugs commanded the largest size in the Human Microbiome Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Women’s Health is projected to witness the highest growth during the forecast period'
Based on Therapeutic Area, the Human Microbiome Market studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health. The Gastrointestinal Disorders commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Women’s Health is expected to grow at the fastest CAGR during the forecast period.
'The Diagnostics is projected to witness the highest growth during the forecast period'
Based on Application, the Human Microbiome Market studied across Diagnostics and Therapeutics. The Therapeutics commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Human Microbiome Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Human Microbiome Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market including DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Ferring Holding SA, Merck Sharp & Dohme Corp., Metabiomics Corporation, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences, Inc., and Yakult Honsha Co., Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Microbiome Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Human Microbiome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Microbiome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Microbiome Market?
4. What is the competitive strategic window for opportunities in the Global Human Microbiome Market?
5. What are the technology trends and regulatory frameworks in the Global Human Microbiome Market?
6. What are the modes and strategic moves considered suitable for entering the Global Human Microbiome Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Disease Outlook
3.5. Technology Outlook
3.6. Application Outlook
3.7. Therapeutic Area Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased focus on human microbiome therapy
5.1.1.2. Human microbiome for drug development, early disease detection, and diagnosis
5.1.2. Restraints
5.1.2.1. Limited expertise and lack of comprehensive research
5.1.3. Opportunities
5.1.3.1. Increasing collaborations and research investments to create growth opportunities
5.1.3.2. Development of human microbiome therapeutic products
5.1.3.3. Increasing demand of Microbiome in probiotics and infant nutrition
5.1.4. Challenges
5.1.4.1. Lack of uncertainty related to drug performance and limited studies proving causal links between microbiota dysbiosis and disease
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. GLOBAL HUMAN MICROBIOME MARKET, BY THERAPEUTIC AREA
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health
10. GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. AMERICAS HUMAN MICROBIOME MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC HUMAN MICROBIOME MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. DuPont de Nemours, Inc.
15.2. Enterome Bioscience
15.3. Evelo Biosciences, Inc.
15.4. Ferring Holding SA
15.5. Merck Sharp & Dohme Corp.
15.6. Metabiomics Corporation
15.7. Osel, Inc.
15.8. Second Genome, Inc.
15.9. Seres Therapeutics, Inc.
15.10. Synlogic Inc.
15.11. Synthetic Biologics Inc.
15.12. Vedanta Biosciences, Inc.
15.13. Yakult Honsha Co., Ltd.
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Disease Outlook
3.5. Technology Outlook
3.6. Application Outlook
3.7. Therapeutic Area Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased focus on human microbiome therapy
5.1.1.2. Human microbiome for drug development, early disease detection, and diagnosis
5.1.2. Restraints
5.1.2.1. Limited expertise and lack of comprehensive research
5.1.3. Opportunities
5.1.3.1. Increasing collaborations and research investments to create growth opportunities
5.1.3.2. Development of human microbiome therapeutic products
5.1.3.3. Increasing demand of Microbiome in probiotics and infant nutrition
5.1.4. Challenges
5.1.4.1. Lack of uncertainty related to drug performance and limited studies proving causal links between microbiota dysbiosis and disease
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. GLOBAL HUMAN MICROBIOME MARKET, BY THERAPEUTIC AREA
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health
10. GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. AMERICAS HUMAN MICROBIOME MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC HUMAN MICROBIOME MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. DuPont de Nemours, Inc.
15.2. Enterome Bioscience
15.3. Evelo Biosciences, Inc.
15.4. Ferring Holding SA
15.5. Merck Sharp & Dohme Corp.
15.6. Metabiomics Corporation
15.7. Osel, Inc.
15.8. Second Genome, Inc.
15.9. Seres Therapeutics, Inc.
15.10. Synlogic Inc.
15.11. Synthetic Biologics Inc.
15.12. Vedanta Biosciences, Inc.
15.13. Yakult Honsha Co., Ltd.
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. QATAR HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. QATAR HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. QATAR HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. QATAR HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. QATAR HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. SPAIN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. SPAIN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. SPAIN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. SPAIN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. SPAIN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. GLOBAL HUMAN MICROBIOME MARKET: SCORES
TABLE 175. GLOBAL HUMAN MICROBIOME MARKET: BUSINESS STRATEGY
TABLE 176. GLOBAL HUMAN MICROBIOME MARKET: PRODUCT SATISFACTION
TABLE 177. GLOBAL HUMAN MICROBIOME MARKET: RANKING
TABLE 178. GLOBAL HUMAN MICROBIOME MARKET: MERGER & ACQUISITION
TABLE 179. GLOBAL HUMAN MICROBIOME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 180. GLOBAL HUMAN MICROBIOME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 181. GLOBAL HUMAN MICROBIOME MARKET: INVESTMENT & FUNDING
TABLE 182. GLOBAL HUMAN MICROBIOME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 183. GLOBAL HUMAN MICROBIOME MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. QATAR HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. QATAR HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. QATAR HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. QATAR HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. QATAR HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. SPAIN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. SPAIN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. SPAIN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. SPAIN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. SPAIN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. GLOBAL HUMAN MICROBIOME MARKET: SCORES
TABLE 175. GLOBAL HUMAN MICROBIOME MARKET: BUSINESS STRATEGY
TABLE 176. GLOBAL HUMAN MICROBIOME MARKET: PRODUCT SATISFACTION
TABLE 177. GLOBAL HUMAN MICROBIOME MARKET: RANKING
TABLE 178. GLOBAL HUMAN MICROBIOME MARKET: MERGER & ACQUISITION
TABLE 179. GLOBAL HUMAN MICROBIOME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 180. GLOBAL HUMAN MICROBIOME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 181. GLOBAL HUMAN MICROBIOME MARKET: INVESTMENT & FUNDING
TABLE 182. GLOBAL HUMAN MICROBIOME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 183. GLOBAL HUMAN MICROBIOME MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 (USD MILLION)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 (USD MILLION)
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 (USD MILLION)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (%)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2025
FIGURE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, 2019 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, 2019 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (%)
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, 2019 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, 2019 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (%)
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2025
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2019 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, 2019 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, 2019 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, 2019 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (%)
FIGURE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2025
FIGURE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, 2019 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
FIGURE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025
FIGURE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2019 VS 2025 (USD MILLION)
FIGURE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2019 VS 2025 (USD MILLION)
FIGURE 53. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 54. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. CANADA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. MEXICO HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 62. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. CHINA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. INDIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 67. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 68. JAPAN HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 69. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 70. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 71. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 72. THAILAND HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 76. FRANCE HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 77. GERMANY HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 78. ITALY HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 79. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 80. QATAR HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 81. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 82. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 83. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 84. SPAIN HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 86. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 87. GLOBAL HUMAN MICROBIOME MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL HUMAN MICROBIOME MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN MICROB
FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 (USD MILLION)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 (USD MILLION)
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 (USD MILLION)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (%)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2025
FIGURE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, 2019 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, 2019 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (%)
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, 2019 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, 2019 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (%)
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2025
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2019 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, 2019 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, 2019 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, 2019 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (%)
FIGURE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2025
FIGURE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, 2019 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
FIGURE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025
FIGURE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2019 VS 2025 (USD MILLION)
FIGURE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2019 VS 2025 (USD MILLION)
FIGURE 53. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 54. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. CANADA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. MEXICO HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 62. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. CHINA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. INDIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 67. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 68. JAPAN HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 69. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 70. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 71. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 72. THAILAND HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 76. FRANCE HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 77. GERMANY HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 78. ITALY HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 79. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 80. QATAR HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 81. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 82. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 83. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 84. SPAIN HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 86. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 87. GLOBAL HUMAN MICROBIOME MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL HUMAN MICROBIOME MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN MICROB
